laptop online games

THOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE AmgenFrida Formann finding her groove, leads CU Buffs into matchup with Tennessee TechBoston 107, Minnesota 105laptop online games 。

None

MLB News: Baseball Auction Could Mean Millions for 10-Year-Old Dodgers Fan

CAPE COD, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- When it comes to modern healthcare, technology is transforming the field of general dentistry, and Harris Dental is leading the charge in delivering innovative, patient-focused care. Known for providing comprehensive services, including preventive dentistry , Harris Dental is revolutionizing routine procedures with cutting-edge technology designed to enhance patient comfort, improve diagnostic accuracy, and streamline treatments. As dental technology advances, Harris Dental has embraced a range of modern tools and techniques that ensure a seamless and comfortable experience for every patient. From routine checkups to advanced gum disease treatment , the practice is committed to delivering the highest quality care for Cape Cod residents. Digital Diagnostics Streamline Preventive Care At Harris Dental, the future of general dentistry starts with advanced diagnostic tools that make routine checkups more effective. Traditional X-rays have given way to digital radiography, offering clearer images while exposing patients to significantly less radiation. This allows the team to identify cavities, bone loss, and other potential issues early, helping to prevent more serious dental problems down the road. In addition to routine adult care, Harris Dental specializes in pediatric dentistry , ensuring that young patients receive compassionate and thorough care tailored to their needs. With the latest technology and a welcoming environment, the practice helps children develop positive dental habits from an early age. Enhanced Comfort Through Cutting-Edge Treatment Methods For patients seeking general dental care, comfort is key. Harris Dental employs laser dentistry to provide minimally invasive treatments for common issues such as gum disease and cavities. Lasers reduce discomfort, shorten recovery times, and often eliminate the need for anesthesia, making even routine procedures more convenient and less stressful for patients. The practice also offers emergency dentistry services , providing immediate care for patients dealing with dental emergencies such as severe pain, injuries, or infections. With a focus on rapid, effective solutions, Harris Dental ensures that patients get relief when they need it most. Personalized Dental Care Through Digital Integration Beyond diagnostics and treatments, digital records and advanced software allow Harris Dental to offer a more personalized approach to general dentistry. Each patient's dental history, preferences, and specific needs are easily accessible to the team, allowing for more effective and streamlined care during routine visits. Intraoral cameras give patients the chance to see exactly what the dentist sees during an examination, creating a collaborative approach to oral health. Patients are empowered to take an active role in their dental care, understanding their diagnosis and treatment options in real-time. Sustainability Meets High-Quality Dental Care Harris Dental is also making strides in sustainability within general dentistry. The practice has transitioned to digital records and imaging, reducing paper waste and the need for disposable materials. This commitment to environmentally friendly practices aligns with their mission to provide top-notch care while minimizing their ecological footprint. Moreover, the practice's use of energy-efficient equipment and materials further supports the goal of running an eco-conscious dental office, making Harris Dental a leader in sustainable healthcare practices. The Future of General Dentistry at Harris Dental As general dentistry continues to evolve, Harris Dental remains at the forefront, integrating the latest technology to improve patient outcomes and comfort. Whether it's preventive dentistry, restorative treatments, or cosmetic procedures, Harris Dental is committed to offering the best in modern dental care to Cape Cod residents. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

( MENAFN - PR Newswire) BEIJING, Dec. 16, 2024 /PRNewswire/ -- In 2024, multiple intelligent NEVs were unveiled in China, many of which are equipped with Huawei's intelligent automotive solutions. The Voyah Dream MPV from Dongfeng's Voyah brand is the first to feature Huawei's ADS 3.0 intelligent driving system. The Deepal L07 from Chang'an Auto uses Huawei's basic intelligent driving solutions. Additionally, AVATR brand of Chang'an Auto released new AVATR 12 at last month, continuing to feature Huawei's full-stack solutions. In July, sales of NEVs in China surpassed those of fuel-powered vehicles for the first time, proving that Chinese consumers are increasingly interested in electric, intelligent cars. Relying on Huawei's strong technical capabilities, related solutions have attracted significant attention in the automotive field. In terms of intelligent driving, Huawei Advanced Driving System has been upgraded to version 3.0. It now integrates various sensors, including lidars, cameras, and mmWave radars. This cutting-edge system, combined with advanced end-to-end intelligent driving algorithms, enhances safety during manual driving, makes intelligent driving more comfortable, and simplifies the parking experience. In terms of the intelligent cockpit, the HarmonyOS cockpit enables drivers to use voice commands to control navigation, windows, seats, and other in-cabin functions. Additionally, HUAWEI SOUND focuses on enhancing auditory perception with features like "smart acoustics, smart sound fields, and smart ambiance." Intelligent automotive optics is a scenario-based solution integrating core optical technology with the automotive industry, advancing the sector's intelligence and connectivity. Currently, the intelligent automotive optics industry features innovative applications like intelligent heads-up displays, intelligent headlight modules, and in-car virtual image displays. Future developments may extend to scenarios such as optical connections. Based on the service-oriented architecture (SOA) concept, the Huawei Intelligent Digital Vehicle Platform (IDVP) boasts a highly centralized hardware architecture and a decoupled, layered software architecture. This empowers automakers to truly realize software-defined vehicles (SDVs), providing users with highly personalized, continuously updated experiences. HUAWEI XMOTION, developed on the IDVP, delivers native cross-domain collaboration, enabling full posture control of the vehicle body with six degrees of freedom for a safer, more comfortable, and superior driving experience. The HUAWEI TMS employs an integrated heat pump system solution with a self-developed nine-way valve, supporting 18 different operating modes. Huawei intelligent vehicle cloud offers an unparalleled user experience with thoughtful services throughout the vehicle's lifecycle, encompassing interaction, care, and security. This includes smart interactions with digital keys, remote control, driving records, Yunkan, and Yunxi, alongside proactive care and security services such as OTA upgrades, vehicle component care, and remote diagnostics. Huawei remains committed to being customer-centric, focusing on intelligent vehicle components to bring intelligence to every vehicle. With Huawei's ongoing investment and innovation in the intelligent vehicle field, it is anticipated that more automotive companies will join Huawei's ecosystem in the future. Together, let's create a better future! SOURCE HUAWEI TECHNOLOGIES CO.,LTD. MENAFN16122024003732001241ID1109000146 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Rachel Reeves and the five claims about her fiddling CV

(Bloomberg) — Germany is headed for months of political deadlock as voters return to the ballot box for another federal election in February and with coalition negotiations potentially lasting several months after that. Lawmakers in Germany’s lower house on Monday backed a confidence motion pushed by Chancellor Olaf Scholz that will trigger a new election on Feb. 23, seven months ahead of schedule. Scholz lost his majority in parliament after his ruling coalition fell apart in November amid infighting. The political uncertainty comes at a delicate time for Europe’s largest economy, which has stagnated for years. In addition to long-festering competitive issues, Donald Trump’s return to the White House threatens to intensify pressure on Germany by raising questions over US support for Ukraine and imposing new tariffs that could hit the country’s exporters. “We need more growth and that’s only possible with more investments into our infrastructure,” Scholz said in the Bundestag on Monday. “This is the task of our generation now — future generations will measure us by this challenge.” Scholz’s Social Democrats, along with his former coalition partners the liberal Free Democrats and the Greens, have suffered in the polls. The conservative CDU/CSU alliance under Friedrich Merz leads with support at around 31%, the far-right Alternative for Germany — or AfD — is second with 19.8% and the SPD third at 17%, according to the latest Bloomberg polling average. The Greens are fourth with 11.2% and the BSW — a new far-left party founded in January — fifth at 7.5%. Lindner’s FDP remains in danger of missing the 5% threshold for getting into parliament with 4.9%. After the election, it will take weeks, if not months until a new coalition government will be formed. Although the CDU/CSU is leading in the polls, it’s far from winning an absolute majority and would need at least one, and potentially more, coalition partners. And the more parties that qualify for seats in parliament the more difficult the arithmetic to build an alliance. The leading candidates have already started to position themselves as best placed to solve the many economic, social and security problems they say confront the country. Merz and the leader of the CDU’s Bavarian sister party CSU, Markus Soeder, will present their parties’ common campaign platform on Tuesday. It proposes an immediate halt on the admission of illegal migrants, income tax cuts, continued support for Ukraine, and a commitment to the constitutional debt brake. In many cases, though, the program doesn’t say how these proposals will be financed. Merz on Monday accused Scholz of “leaving the country in one of the biggest economic crises of the post-war period,” adding that “what lies ahead of us will be a tremendous effort.” The next chancellor will need to secure funds and public support for massive investments needed to upgrade crumbling infrastructure, shore up defense capabilities and shift to a more technologically advanced and climate-friendly economy. Alongside reviving growth, government borrowing as well as irregular migration will be key election topics. The German economy is set to shrink for a second straight year due to dwindling foreign demand and the jump in energy prices that followed Russia’s invasion of Ukraine. There are also new headwinds from possible US trade levies and political uncertainty before snap elections. “No industry sector is really optimistic about 2025 — the new federal government has a lot of work to do,” said Klaus Wohlrabe from Ifo Institut, one of Germany’s most renowned economic research institutes. About a third of companies in Germany expect their economic situation to worsen next year, according to its latest survey. Some 56% of surveyed companies anticipate their situation to remain unchanged, and just 13% expect business development to pick up next year. “Companies currently see no signs of an economic upturn. Given that the economy was already doing poorly in 2024, these figures are worrying,” Wohlrabe said. What Bloomberg Economics Says... “Germany’s problems won’t go away on their own. Retooling the economy for the future, improving productivity and tackling the causes of high energy costs urgently need the next government’s attention.” —Martin Ademmer and Jamie Rush. Click here for the full GERMANY INSIGHT In the Bundestag, a majority of 394 lawmakers backed Monday’s no-confidence measure. Scholz can now ask President Frank-Walter Steinmeier to dissolve the parliament and formally set the election date. The fellow Social Democrat has indicated that he’ll go along with Scholz’s timetable. So far there have only been two cases in which German chancellors have used this parliamentary instrument with the aim of losing a confidence vote in order to bring about new elections: Former CDU Chancellor Helmut Kohl did it in 1982 and his SPD successor Gerhard Schroeder in 2005. Kohl won, while Schroeder lost. Robert Habeck, the current economy minister and vice chancellor and the lead candidate for the Greens, warned that domestic political crises were distracting countries from seeing the bigger picture. “While we in Central Europe are largely preoccupied with ourselves, the world is not standing still,” Habeck said. “And it is not a good state of affairs.”

Bradley/Grombacher: Negligence Lawsuit Alleges Roblox, Epic Games Prays on Young Minds, Creating Addiction Among Minors

Stock market today: Rising tech stocks pull Wall Street to another record

Princeton 66, Rutgers 493,700 people killed or missing since Israel’s siege of northern Gaza, says Media OfficeSwansea boss Luke Williams thought his side were second best for the majority of the contest despite earning a 2-1 win at Derby. The Swans stunned Pride Park into silence with less than two minutes on the clock when Zan Vipotnik sent a bullet past Jacob Widell Zetterstrom before Ronald slotted home his first of the season in the 14th minute. Cyrus Christie brought Tom Barkhuizen down inside the box and Nathaniel Mendez-Laing dispatched the resulting penalty to cut the deficit in half and, despite piling on the pressure, Derby succumbed to a second home defeat of the season. Williams told a press conference: “We started the game very well, we were good up until we scored the second goal then we lost the grip on the game and I thought Derby were the better team. “The next thing for us we have to be able to maintain that level throughout the game and we weren’t able to do that to be quite honest today. “They made it difficult, reacted very well after the second goal and didn’t go under, far from it.” Swansea leapfrogged their opponents into the top half of the table with their sixth win of the season and took three points back to south Wales following two last-minute defeats by Burnley and Leeds heading into the match. Williams added: “We’ve recently conceded late goals but they’re a very resilient group and we saw it out in the end. “We’ve dominated games a lot but probably failed to score when we’ve been that dominant and tonight we managed to score the goals when we were dominant. “We scored the goals at the right time today.” Derby had been unbeaten in their last three matches coming into this one but Paul Warne put defeat down to a poor start. He said: “We conceded two and didn’t get close enough, weren’t aggressive enough, not enough body contact and looked soft, that’s my fault. “Maybe I didn’t message it properly. Sometimes it doesn’t come down to shape and tactics but I thought that was what the difference was. “Credit Swansea for the win but after the 25 mins it looked like we would score. I really enjoyed it, that’s the truth. I had 70 minutes of a team giving everything, I don’t think we’ve had that many attempts in the Championship this season. “It’s a rude awakening, last year we would’ve won that 4-2.” We do not moderate comments, but we expect readers to adhere to certain rules in the interests of open and accountable debate.